Mebiopharm

Targeted nano-particle based drug delivery for cancer treatments

placeMinato City, Tokyo, Japan calendar_todayFounded 2002 language mebiopharm.com

Innovation

11 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 738 times.

YearFilings
20131
20141
20151
20161
20171

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon